211 related articles for article (PubMed ID: 10190897)
41. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
Shinohara H; Yagita H; Ikawa Y; Oyaizu N
Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
[TBL] [Abstract][Full Text] [Related]
42. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.
Watanabe T; Yamaguchi K; Takatsuki K; Osame M; Yoshida M
J Exp Med; 1990 Sep; 172(3):759-65. PubMed ID: 2388034
[TBL] [Abstract][Full Text] [Related]
43. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
44. [Fas antigen (CD95) expressions and apoptosis of neoplastic cells from various lymphoid malignancies including adult T-cell leukemia/lymphoma].
Sasao T; Yoshida M; Ichikawa Y
Nihon Rinsho; 1996 Jul; 54(7):1986-91. PubMed ID: 8741700
[TBL] [Abstract][Full Text] [Related]
45. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.
Sugahara K; Yamada Y; Hiragata Y; Matsuo Y; Tsuruda K; Tomonaga M; Maeda T; Atogami S; Tsukasaki K; Kamihira S
Int J Cancer; 1997 Jul; 72(1):128-32. PubMed ID: 9212233
[TBL] [Abstract][Full Text] [Related]
46. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers.
Berneman ZN; Gartenhaus RB; Reitz MS; Blattner WA; Manns A; Hanchard B; Ikehara O; Gallo RC; Klotman ME
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3005-9. PubMed ID: 1348363
[TBL] [Abstract][Full Text] [Related]
47. Fas expression prevents cholangiocarcinoma tumor growth.
Pickens A; Pan G; McDonald JM; Vickers SM
J Gastrointest Surg; 1999; 3(4):374-81; discussion 382. PubMed ID: 10482689
[TBL] [Abstract][Full Text] [Related]
48. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
[TBL] [Abstract][Full Text] [Related]
49. Modulation of fas-mediated apoptosis in osteosarcoma cell lines.
Hamada T; Komiya S; Yano H; Zenmyo M; Hiraoka K; Inoue A; Morimatsu M
Int J Oncol; 1999 Dec; 15(6):1125-31. PubMed ID: 10568818
[TBL] [Abstract][Full Text] [Related]
50. Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells.
Mori N; Fujii M; Iwai K; Ikeda S; Yamasaki Y; Hata T; Yamada Y; Tanaka Y; Tomonaga M; Yamamoto N
Blood; 2000 Jun; 95(12):3915-21. PubMed ID: 10845928
[TBL] [Abstract][Full Text] [Related]
51. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells.
Yoshie O; Fujisawa R; Nakayama T; Harasawa H; Tago H; Izawa D; Hieshima K; Tatsumi Y; Matsushima K; Hasegawa H; Kanamaru A; Kamihira S; Yamada Y
Blood; 2002 Mar; 99(5):1505-11. PubMed ID: 11861261
[TBL] [Abstract][Full Text] [Related]
52. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis.
Kamihira S; Yamada Y; Tomonaga M; Sugahara K; Tsuruda K
Br J Haematol; 1999 Dec; 107(4):851-60. PubMed ID: 10606894
[TBL] [Abstract][Full Text] [Related]
53. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-10 gene expression in adult T-cell leukemia.
Mori N; Gill PS; Mougdil T; Murakami S; Eto S; Prager D
Blood; 1996 Aug; 88(3):1035-45. PubMed ID: 8704212
[TBL] [Abstract][Full Text] [Related]
55. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
Cascino I; Papoff G; De Maria R; Testi R; Ruberti G
J Immunol; 1996 Jan; 156(1):13-7. PubMed ID: 8598453
[TBL] [Abstract][Full Text] [Related]
56. Fas expression and Fas monoclonal antibody-induced apoptosis in a human squamous cell carcinoma cell line, SCC-25.
Seta C; Fujita M; Muraki Y; Fukuda J; Kobayashi S; Haneji T
J Oral Pathol Med; 2000 Jul; 29(6):271-8. PubMed ID: 10890558
[TBL] [Abstract][Full Text] [Related]
57. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.
Re D; Hofmann A; Wolf J; Diehl V; Staratschek-Jox A
Exp Hematol; 2000 Jan; 28(1):31-5. PubMed ID: 10658674
[TBL] [Abstract][Full Text] [Related]
58. Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing.
Munker R; Marini F; Jiang S; Savary C; Owen-Schaub L; Andreeff M
Hematol Cell Ther; 1997 Apr; 39(2):75-8. PubMed ID: 9168303
[TBL] [Abstract][Full Text] [Related]
59. Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax.
Tatewaki M; Yamaguchi K; Matsuoka M; Ishii T; Miyasaka M; Mori S; Takatsuki K; Watanabe T
Blood; 1995 Oct; 86(8):3109-17. PubMed ID: 7579405
[TBL] [Abstract][Full Text] [Related]
60. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.
Ishikawa C; Kawakami H; Uchihara JN; Senba M; Mori N
Biochim Biophys Acta; 2013 Jun; 1833(6):1542-52. PubMed ID: 23507197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
